Walmart, Walgreens, and CVS are expanding their healthcare offerings by introducing testing and treatment options typically only available at doctor's offices. In an effort to capture a larger share of healthcare spending, these retail giants are taking advantage of new state laws that allow pharmacists to treat minor illnesses. Walmart pharmacists in 12 states now offer testing and treatment services for strep throat, flu, and Covid-19. Walgreens plans to roll out a similar offering across 13 states, while CVS pharmacists in 10 states will evaluate symptoms and prescribe flu antiviral medicine and cough suppressants, although they won't provide tests.
These developments come as pharmacists have been temporarily granted authorization to administer tests and vaccines during the pandemic, leading to a growing realization that they can do more than simply dispense medication. This recognition has led to a surge in proposed bills at the state level, with 44 of them becoming law in 2022, expanding pharmacists' scope of practice and payment options. However, at the federal level, pharmacists are not yet recognized as healthcare providers by Medicare and insurance, meaning patients must bear the cost of these services, which can be pricey.
To address the cost concerns, bipartisan legislation has been introduced in the US House of Representatives. The proposed bill, called the Equitable Community Access to Pharmacist Services Act, would provide Medicare coverage for pharmacist-administered tests and treatments. If passed, this legislation would create a pathway for patients to receive reimbursement.
While these new options from retail chains and drugstores offer convenience due to their widespread geographic coverage, critics have raised concerns. The American Medical Association argues that pharmacists lack the necessary education and training to assume the roles of physicians. Additionally, the bill proposed in the House is opposed by the AMA, as they believe it would further burden overworked healthcare professionals. Pharmacies, on the other hand, point out the increasing shortage of primary care physicians and argue that technology and automation can help alleviate pharmacists' workload.
As the Delta variant continues to contribute to an increase in Covid hospitalizations, the Centers for Disease Control and Prevention are discussing new vaccines that will be available in the fall. Walmart is encouraging patients to utilize their mobile app or walk into their stores to access these new treatments. Currently, the services are available in 12 states, including Arkansas, Colorado, Florida, Idaho, Iowa, Kansas, Kentucky, Michigan, Minnesota, South Dakota, Tennessee, and Washington. Walmart's aim is not only to attract patients who would typically visit a doctor but also to offer care to individuals who may not seek treatment otherwise.
Overall, the expansion of healthcare services by retail giants reflects the changing landscape of the healthcare industry. With the increasing acceptance of pharmacists' roles in providing testing and treatment, and potential legislative changes on the horizon, more accessible and cost-effective options may become available to patients in the future.